ELLEN LONSDALE: Open Payments
NPI 1376139568 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 123 payments from 14 companies in 2025. Trend: 2023 $3,549 · 2024 $2,150 · 2025 $1,801
Food & beverage: $1,702Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $328 |
| Amgen Inc. | 28 | $322 |
| Janssen Biotech, Inc. | 31 | $300 |
| GlaxoSmithKline, LLC. | 18 | $277 |
| ABBVIE INC. | 18 | $191 |
| Globus Medical, Inc. | 1 | $145 |
| UCB, Inc. | 4 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Medtronic, Inc. | 1 | $37 |
| Almatica Pharma LLC | 1 | $23 |
Products named: COSENTYX, TREMFYA, BENLYSTA, Senza, RINVOQ, KRYSTEXXA, ENBREL, TAVNEOS.
Industry payments across TX — which companies pay providers there.
